Enzyre is a developer of diagnostic technology. The ENZYPAD enables real near patient blood coagulation analysis, with the measured data being effortlessly made available to the treating physician, irrespective of his or her physical location. The company seeks to create a point of care (POC) diagnostic platform that will measure a multitude of enzymatic reactions based on chemiluminescence.
Health Care, Medical Device, blood coagulation
Between €1 million-€ 2.5 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Enzyre? We’re happy to assist you with our Startup Sourcing service.